Valuation: ABL Diagnostics

Market Cap 4.02Cr 4.57Cr 3.73Cr 3.43Cr 6.44Cr 442.35Cr 6.55Cr 45Cr 17Cr 215.76Cr 17Cr 17Cr 748.53Cr P/E 2024
123x
P/E 2025 50x
Enterprise Value 4.11Cr 4.67Cr 3.82Cr 3.51Cr 6.59Cr 452.62Cr 6.7Cr 46Cr 18Cr 220.77Cr 18Cr 17Cr 765.91Cr EV / Sales 2024
70,98,474x
EV / Sales 2025 61,85,843x
Free-Float
6.2%
Yield 2024
2.03%
Yield 2025 3.67%
1 day+0.80%
1 week+7.69%
Current month-9.35%
1 month+4.13%
3 months+0.80%
6 months-25.88%
Current year-16.00%
1 week 2.18
Extreme 2.18
2.54
1 month 2.18
Extreme 2.18
2.96
Current year 2.12
Extreme 2.12
5
1 year 2.12
Extreme 2.12
5.75
3 years 2.12
Extreme 2.12
9.7
5 years 1.99
Extreme 1.9875
26
10 years 1.28
Extreme 1.275
26
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
02/06/26
Advanced Biological Laboratories SA
SellCompany -57,692 0.3580%
27/05/26
Advanced Biological Laboratories SA
SellCompany -51,900 0.3221%
17/03/26
Advanced Biological Laboratories SA
SellCompany 54,745 0.3397%
Change 5-day change 1-year change 3-year change Capi.($)
+0.80%+7.69%-55.40%-71.36% 4.57Cr
+0.18%+1.94%-19.93%-11.85% 18TCr
+0.15%-1.85%-10.87%-7.81% 10TCr
+1.49%-0.95%+3.96%+58.40% 5.94TCr
-1.13%-2.60%+26.37%+54.76% 5.07TCr
-0.12%-4.35%-16.22%-42.24% 4.21TCr
+1.21%-8.47% - - 3.18TCr
-1.33%-9.62%-18.45%-46.03% 2.72TCr
-0.82%-1.92%+56.39%-5.79% 2.51TCr
+0.03%-4.74%-6.58%-9.24% 2.05TCr
Average +0.07%-2.30%-4.53%-9.02% 5.37TCr
Weighted average by Cap. +0.17%-1.51%-5.88%-0.05%

Financials

2024 2025
Net sales 5.87 6.67 5.45 5.01 9.4 646.28 9.57 65.2 25.43 315.23 25.05 24.51 1.09T 7.97 9.06 7.4 6.81 12.76 877.1 12.99 88.49 34.52 427.81 34 33.27 1.48T
Net income 3L 3L 3L 2L 5L 3.14Cr 5L 31.68L 12.36L 1.53Cr 12.17L 11.91L 5.31Cr 10L 11.22L 9L 8L 15.81L 11Cr 16.09L 1.1Cr 42.75L 5.3Cr 42.12L 41.21L 18Cr
Net Debt 20.24L 23.01L 18.8L 17.29L 32.43L 22Cr 33.01L 2.25Cr 87.69L 11Cr 86.39L 84.52L 38Cr 9L 10.6L 9L 8L 14.94L 10Cr 15.21L 1.04Cr 40.41L 5.01Cr 39.81L 38.95L 17Cr
Logo ABL Diagnostics
ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.
Employees
22
Date Price Change Volume
24/26/24 2.520 +0.80% 2,334
23/26/23 €2.500 +6.84% 6,147
22/26/22 €2.340 -2.50% 5,809
21/26/21 €2.400 +1.69% 2,969
20/26/20 €2.360 +0.85% 64,901

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABLD Stock